BSE filing, NSE: TITANBIO. Summary written from the filing by ALFA Finder's alert engine.
Titan Biotech Ltd: key numbers
- Share price
- ₹352.00
- Market cap
- ₹1,818 Cr
- Revenue (annual)
- ₹206.2 Cr
- Net profit (annual)
- ₹29.89 Cr
- P/E (TTM)
- 53.7×Sector 34.1×
- Promoter holding
- 55.78%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Titan Biotech Ltd
All →Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Titan Biotech Other Announcement
Titan Biotech Limited has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Titan Biotech Capital Structure Change
Titan Biotech increased its authorised share capital from Rs. 10 Crore to Rs. 10.40 Crore, following shareholder approval at the 34th Annual General Meeting.
Titan Biotech Annual General Meeting
Titan Biotech Limited held its 34th Annual General Meeting on September 29, 2026. The meeting transacted ordinary and special business, including financial adoption and director appointments.
Titan Biotech Other Announcement
Titan Biotech has dispatched letters to shareholders with unregistered emails, providing web links to access the FY 2025-26 Annual Report and 34th AGM Notice.
Titan Biotech Annual Report
Titan Biotech filed its 34th Annual Report and AGM Notice for the financial year 2025-26. The AGM is scheduled for September 29, 2026.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels approved a 1:1 bonus issue of 2,49,98,000 shares, subject to shareholder approval. No cash is paid; the shares come from free reserves.